Company / Accounts Receivable
LifeMD, Inc. Accounts Receivable History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$9.3M
FY2025
5-year range
$980.1K / $9.3M
FY2021-FY2025
Trend
+76.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $3M to $9M over the past 2 years.
Based on SEC 10-K filings.
$9M in FY2025 with a 5-year CAGR of +70.4%.
Improved from $3M to $9M over the past 2 years.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +48.6%
- 5-Year CAGR
- +70.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +70.4%, indicating consistent growth.
- In FY2025, accounts receivable increased 76.3% year-over-year.
- Lowest accounts receivable in the period was in FY2019.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.3M | +76.3% |
| FY2024 | $5.3M | +86.2% |
| FY2023 | $2.8M | +0.0% |
| FY2022 | $2.8M | +189.2% |
| FY2021 | $980.1K | +51.1% |
| FY2020 | $648.4K | +565.4% |
| FY2019 | $97.4K | -1.6% |
| FY2018 | $99.1K | -75.2% |
| FY2017 | $398.8K | +158.2% |
| FY2016 | $154.4K | +0.0% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026